<DOC>
	<DOC>NCT01472497</DOC>
	<brief_summary>Insulin resistance is often complicated with hypertension. AGE and inflammation play important roles in insulin resistance. Some studies reported that pioglitazone, insulin sensitizer, is effective for patients with insulin resistance, however, the mechanisms are still unclear. The aim of this study to evaluate the effect of pioglitazone compared with glimepiride on AGE, inflammatory cytokines and cardiac markers (BNP and echo) in hypertensive patients during oral glucose tolerance test.</brief_summary>
	<brief_title>Effects of Pioglitazone in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Hypertension with insulin resistance Chronic systolic heart failure, ACS</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>oral glucose tolerance test</keyword>
	<keyword>AGE</keyword>
	<keyword>inflammatory cytokine</keyword>
</DOC>